Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Instagram Outage Disrupts Thousands of U.S. Users 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Fairfield, NJ, Dec. 04, 2017 -- Redi-Data, Inc., a leading provider of healthcare professional, consumer and business data and email lists, announced today, that a leading top 12 global pharmaceutical company has reached an agreement to license its comprehensive database of over 1.2 million HCP emails. The company will leverage Redi-Data’s healthcare email database across its portfolio of leading brands and best-in-class products to target and streamline marketing outreach initiatives.
The Enterprise License Agreement provides the pharmaceutical leader with cost-effective access to email data by specialty and a wide range of medical professions, including MDs, DOs, NPs, PAs, Dentists and Nurses. The company will also leverage Redi-Data’s expert campaign coordination and support, including email deployment, sophisticated reporting, database management and handling of opt-outs.
“This is a significant partnership for Redi-Data,” stated Thomas Buckley, President of Redi-Data, Inc. “The quality of both our data and client support were evaluated as part of this process and we remain committed to delivering the best value to our clients while turning the best data into better business.”
About Redi-Data, Inc.
Redi-Data, Inc. is a leading provider of healthcare professional, consumer and business postal and email lists. As an official database licensee of several leading professional associations, including the American Medical Association (AMA), Redi-Data provides physician information from the most trusted names in medical marketing. Clients across varying industries use Redi-Data’s high-quality lists, data services and turn-key marketing solutions to reach their target audience accurately and affordably. Headquartered in Fairfield, NJ, Redi-Data has sales offices in Marlton, NJ and Sunrise, FL.
Redi-Data Contact
Vincent Stallone
(973) 227-4380
[email protected]
www.redidata.com
Media Contact
Umi Haft-Funke
(973) 461-4800
[email protected]
